Abstract Introduction Colonization with Group B Streptococcus in pregnancy is a major risk
factor for neonatal infection. Universal screening for maternal streptococcal colonization and …

Background Community-acquired pneumonia (CAP) causes substantial morbidity and
mortality in adults worldwide. The etiology of CAP often remains uncertain, and therapy is …

With growing concerns about Group B streptococcal (GBS) infections and their adverse
effects on perinatal pregnancies, including infection, premature delivery, neonatal …

Abstract Objective Group B streptococcus (GBS) has been associated with adverse
pregnancy outcomes, but few prospective studies have assessed its prevalence in low‐and …

Group B Streptococcus (GBS) is one of the leading infection-related causes of adverse
maternal and neonatal outcomes. This includes chorioamnionitis, which leads to preterm …

Background Streptococcus agalactiae (GBS) is the causative pathogen of puerperal sepsis
in pregnant women and pneumonia, sepsis and meningitis in infants. Infection of GBS is …

Abstract Aims To investigate Group B Streptococcus (GBS) colonization in pregnancy;
adherence to antenatal GBS screening and adherence to the intrapartum antibiotics protocol …

The proportion of Group B Streptococcus (GBS) colonisation in pregnant women> 35 weeks
of gestation was 18% and 49% by culture and real-time PCR respectively in selected …

Abstract Background Group B streptococcus (GBS) is considered a leading cause of
maternal and infant morbidity and mortality. Molecular diagnosis is a routinely used …

ABSTRACT Group B Streptococcus (GBS) causes serious neonatal infection via vertical
transmission. The prenatal GBS screening test is performed at the late stage of pregnancy to …